Gianni Panagiotou

Prof. Dr. Gianni Panagiotou

Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.de

Curriculum vitae

Forschungsschwerpunkte
  • Mikrobiom bei Gesundheit und Krankheit
  • Systembiologie von Infektionskrankheiten
  • Personalisierte Ernährung

Publikationen

Nikitashina L, Chen X, Radosa L, Li K, Straßburger M, Seelbinder B, Böhnke W, Vielreicher S, Nietzsche S, Heinekamp T, Jacobsen ID, Panagiotou G, Brakhage AA# (2025) The murine lung microbiome is disbalanced by the human-pathogenic fungus Aspergillus fumigatus resulting in enrichment of anaerobic bacteria. Cell Rep 44(3), 115442.
Nychas E*, Marfil-Sánchez A*, Chen X, Mirhakkak M, Li H, Jia Q, Xu A, Nielsen HB, Niewdorp M, Loomba R, Ni Y#, Panagiotou G# (2025) Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease. Microbiome 13(1), 10.
Wang J, Qin Y, Wu Q, Zeng D, Gao X, Wang Q, Li Z, Ni Y#, Li H, Zhang P, Guo J, Ma W, Maitusun M, Jin X, Chen M, Zhu L, Lu Q, Chen Q, Wu Y, Lin C, Han R, Cheng D, Ni J, Wang X, Yao F, Zhuang J, Xia J, Liu D, Lu Y, Kang P, Yu S, Chen A, Zhang Y, Li Q, Ge W, Long X, Jiang Z, Guan Z, Jin Z, Jin P, Li T, Shu J, Yang J, Wang J, Jiang N, Qian J, Jung Y, Zhang H, Yang Q, Ma L, Wu X, Huang X, Si D, Ren J, Qiao H, Guo Y, Huang Z, Wang W, Deng W, Bi L, Zhao D, Li Y, Lau RWH, Tham YC, Ma X, Ma J, Shen D, Zhang S, Guan H, Zou W, Guo M, Guan X, Yang X, Xu A, Wu J, Panagiotou G, Tse MA, Kim J, Wu E, Thalmann D, Magnenat Thalmann N, Fregni F, Wong TY, Jia W, Zeng R#, Lim CT#, Sheng B#, Li H# (2025) An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial. Nature Medicine 31(7), 2255-2268.
Wang Y*, Wu J*, Yao J, Chen J, Cheng KKY, Yuen-man Ho M, Lee CH, Siu-Ling Lam K, Tse MA, Panagiotou G, Xu A# (2025) Gut microbiome-adipose crosstalk modulates soluble IL-6 receptor influencing exercise responsiveness in glycemic control and insulin sensitivity. Cell Metab 37(12), 2323-2341.
Xiong L, Beyer D, Liu N, Lehmann T, Neugebauer S, Schaeuble S, Sommerfeld O, Ernst P, Svensson CM, Nietzsche S, Scholl S, Bruns T, Gaßler N, Gräler MH, Figge MT, Panagiotou G, Bauer M, Press AT# (2025) Targeting protein kinase C-α prolongs survival and restores liver function in sepsis: Evidence from preclinical models. Pharmacol Res 212, 107581.
Xu LL, McIlroy SE, Ni Y, Guibert I, Chen J, Rocha U, Baker DM#, Panagiotou G# (2025) Chemical pollution drives taxonomic and functional shifts in marine sediment 2 microbiome, influencing benthic metazoans. ISME Commun 5(1), ycae141.
Xu LL, Zhou Z, Schäuble S, Vivas W, Dlubatz K, Bauer M, Weis S, Singer M, Lukaszewski R, Panagiotou G# (2025) Multi-omics and -organ insights into energy metabolic adaptations in early sepsis onset. Adv Sci 12(30), e04418.
Zhang L*, Marfil-Sánchez A*, Kuo T-H, Seelbinder B, van Dam L, Depetris-Chauvin A, Jahn L J, Sommer M O A, Ni Y#, Panagiotou G# (2025) Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes. Nat Microbiol 11(1), 94-110.
Chen J, Lu RS, Diaz-Canestro C, Song E, Jia X, Liu Y, Wang C, Cheung CKY, Panagiotou G#, Xu A# (2024) Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in obese Chinese. Comput Struct Biotechnol J 23(2024), 791-800.
Chen J*, Wang Y*, Xu A, Panagiotou G# (2024) The human gut mycobiome and its potential as a regulator of the host’s metabolic health. In: Brakhage AA, Kniemeyer O, Zipfel PF (eds.) The Mycota - Human and Animal Relationships 3. 6, pp. 121-133. Springer, Cham. ISBN: 978-3-031-64852. (Review)

Aktuelles